KALA BIO, Inc.
KALA
$9.31
$0.536.04%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 7.55% | -15.29% | -9.13% | -11.15% | -13.00% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.88% | -9.56% | 1.26% | -8.93% | 4.26% |
| Operating Income | -12.88% | 9.56% | -1.26% | 8.93% | -4.26% |
| Income Before Tax | -16.45% | 24.22% | 5.24% | -2.83% | 8.01% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -16.45% | 24.22% | 5.24% | -2.83% | 8.01% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -16.45% | 24.22% | 5.24% | -2.83% | 8.01% |
| EBIT | -12.88% | 9.56% | -1.26% | 8.93% | -4.26% |
| EBITDA | -12.90% | 9.63% | -1.28% | 8.84% | -4.47% |
| EPS Basic | 45.82% | 66.41% | 45.25% | 43.33% | 27.51% |
| Normalized Basic EPS | 46.72% | 66.03% | 4.56% | 55.01% | 24.70% |
| EPS Diluted | 45.82% | 66.41% | 45.25% | 43.33% | 27.51% |
| Normalized Diluted EPS | 46.72% | 66.03% | 4.56% | 55.01% | 24.70% |
| Average Basic Shares Outstanding | 114.94% | 125.58% | 73.07% | 81.46% | 26.90% |
| Average Diluted Shares Outstanding | 114.94% | 125.58% | 73.07% | 81.46% | 26.90% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |